I would say its a medication no longer protected by patent that Sanofi has acquired and they want to up the horse power with a rapid delivery system to make it super-charged and effectively give that medication an advantage over any other pharma that wants to take up that medication.
I would say it is a medication that when it is used, it is only used when it is seriously needed in a life and death situation so rapid onset and delivery is a competitive advantage in the application of a serious life and death medication.
Not too many Sanofi medications fit that bill. I would say.
It is a very short list. I would say.
I would say its a medication no longer protected by patent that...
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.3¢ |
Change
-0.003(1.61%) |
Mkt cap ! $160.3M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.0¢ | $82.79K | 539.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18124 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 108897 | 1 |
View Market Depth
| Last trade - 15.46pm 12/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |